Hänseler

Herisau, Switzerland
Hybrid — also manufactures internal programs
Semi-solids & Liquids Oral Liquids Packaging & Labeling
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Hänseler

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Herisau, Switzerland
Website
Modalities
Semi-solids & Liquids, Oral Liquids, Packaging & Labeling
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Hänseler

Hänseler makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Semi-solids & Liquids, Oral Liquids, Packaging & Labeling. 1 manufacturing site registered with the U.S. FDA. Website: https://www.haenseler.ch/en/competences/cdmo-portfolio/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Hänseler FDA Inspection History

2025-09
2022-10
NAI VAI OAI
Date Site Type Observations Classification
2025-09-04
Hanseler AG
Herisau Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2022-10-21
Hanseler AG
Herisau Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hänseler FDA 483 Findings 4 observations · 2022-10-21 → 2022-10-21 ?

By subsystem

  • Documentation & Records 2 (50.0%)
  • Laboratory Controls 1 (25.0%)
  • CAPA 1 (25.0%)

By severity

  • 3 — Moderate: 2
  • 2 — Minor: 2
  • Repeat observations: 0

Most severe findings

  • Moderate (3) CAPA 2022-10-21 21 CFR 211.192
    Investigations of discrepancies, failures

    "There is a failure to thoroughly review whether or not the batch has been already distributed."

  • Moderate (3) Laboratory Controls 2022-10-21 21 CFR 211.84(d)(2)
    Component written specification

    "Component testing is deficient in that each component is not tested for conformity with all appropriate written specifications for purity, strength, and quality."

  • Minor (2) Documentation & Records 2022-10-21 21 CFR 211.110(a)
    Control procedures to monitor and validate performance

    "Control procedures are not established which validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product."

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Hänseler

How many FDA inspections does Hänseler have on record?
CDMO Signal tracks 2 FDA inspections for Hänseler, sourced from the FDA inspection database. See the full inspection history above.
Has Hänseler received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Hänseler.
Does Hänseler have a CDMO Signal Score?
Not yet. Hänseler is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Hänseler for a manufacturing program?
Use the free AI matchmaker to compare Hänseler against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

DMX Pharma
Milan, Italy
Oral Solid Dose, Oral Liquids, Semi-solids & Liquids, Softgels, Sterile Injectables, Inhalation & Nasal, Packaging & Labeling
Formulated Solutions
Largo, Florida, United States
Topicals, Inhalation & Nasal, Finished Dosage Forms, Oral Liquids, Semi-solids & Liquids
Mikart
Atlanta, Georgia, United States
Oral Solid Dose, Oral Liquids, Controlled Substances, Packaging & Labeling
Pierre Fabre CDMO
Castres, France
Oral Solid Dose, Finished Dosage Forms, Non-sterile Liquids, Semi-solids & Liquids, Small Molecule API, High-Potency APIs, Packaging & Labeling
PTI Georgia (Pharma Tech Industries)
United States
Oral Solid Dose, Semi-solids & Liquids, Packaging & Labeling

Compare Hänseler with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Hänseler
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.